Loading…
Sunshield Chemicals (BSE 530845)₹1,128−1.97%Specialty Chemicals
In the Mar 2026 quarter (standalone), Sunshield Chemicals reported sales of ₹110 Cr, up 0.1% from Mar 2025, and net profit of ₹11.03 Cr, up 83.2% year on year. For the year to Mar 2026, sales were ₹442 Cr and net profit ₹30.08 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 67.02 | 66.09 | 65.08 | 86.05 | 78.03 | 93.17 | 85.03 | 110 | 114 | 122 | 95.08 | 110 |
| Expenses | 58.17 | 57.21 | 55.20 | 73.26 | 70.20 | 85.32 | 78.21 | 99.30 | 101 | 108 | 86.32 | 93.28 |
| Operating Profit | 8.96 | 8.96 | 10.96 | 11.96 | 7.97 | 7.97 | 6.97 | 11.96 | 12.96 | 13.96 | 8.96 | 15.93 |
| OPM % | 12.9% | 13.9% | 15.9% | 13.9% | 9.9% | 8.0% | 7.9% | 10.0% | 10.9% | 10.9% | 9.9% | 15.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.00 |
| Interest | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 0.99 | 0.00 |
| Depreciation | 2.01 | 1.99 | 1.99 | 2.01 | 2.01 | 2.99 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Profit before tax | 4.99 | 4.99 | 6.99 | 9.01 | 3.99 | 3.99 | 1.99 | 7.99 | 9.01 | 10.01 | 6.99 | 13.99 |
| Tax % | 29.0% | 29.1% | 30.0% | 30.1% | −6.0% | 26.0% | 31.1% | 24.1% | 26.0% | 25.0% | 26.0% | 24.0% |
| Net Profit | 4.01 | 4.01 | 5.02 | 6.02 | 4.01 | 3.01 | 2.01 | 6.02 | 7.02 | 7.03 | 5.02 | 11.03 |
| EPS (Rs) | 4.35 | 4.40 | 5.82 | 6.80 | 4.55 | 3.61 | 1.84 | 6.51 | 7.74 | 8.23 | 5.57 | 12.11 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 150 | 166 | 183 | 190 | 181 | 199 | 244 | 245 | 283 | 366 | 442 | 442 |
| Expenses | 140 | 157 | 169 | 174 | 165 | 169 | 214 | 215 | 244 | 333 | 390 | 389 |
| Operating Profit | 9.97 | 8.97 | 15.94 | 15.95 | 16.93 | 29.87 | 30.86 | 30.87 | 39.87 | 33.88 | 51.78 | 51.81 |
| OPM % | 7.0% | 5.0% | 8.0% | 8.9% | 8.9% | 14.9% | 12.9% | 12.9% | 13.9% | 9.0% | 12.0% | 11.7% |
| Other Income | 2.99 | −1.99 | 1.99 | 0.99 | 0.00 | 0.00 | 18.99 | 1.99 | 0.99 | 2.99 | 2.99 | 1.98 |
| Interest | 10.95 | 8.96 | 9.97 | 10.95 | 9.96 | 6.98 | 4.98 | 6.97 | 7.97 | 8.96 | 4.98 | 4.97 |
| Depreciation | 4.99 | 6.01 | 6.01 | 6.01 | 5.99 | 6.01 | 6.01 | 6.01 | 7.01 | 10.01 | 11.01 | 12.04 |
| Profit before tax | −2.99 | −7.99 | 1.99 | 0.00 | 0.99 | 17.01 | 38.98 | 19.01 | 27.01 | 17.99 | 39.97 | 40.00 |
| Tax % | −75.0% | −16.0% | 20.1% | 0.0% | 46.1% | 15.0% | 30.1% | 28.0% | 30.1% | 19.1% | 25.0% | — |
| Exceptional items | 0.00 | −2.01 | 0.00 | −2.01 | −1.01 | 0.00 | 12.03 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −1.01 | −7.02 | 1.01 | 0.00 | 1.01 | 14.05 | 27.10 | 14.04 | 19.07 | 15.05 | 30.08 | 30.10 |
| EPS (Rs) | −0.96 | −7.57 | 1.37 | 0.24 | 0.72 | 16.09 | 31.21 | 15.51 | 21.41 | 16.55 | 33.65 | 33.65 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 5.0% | 11.0% | 9.0% | 13.0% | 9.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.99 | 7.01 | 6.99 | 7.00 | 6.99 | 7.00 | 7.02 | 6.99 | 6.99 | 6.99 | 6.99 | 8.99 |
| Reserves | 10.02 | 9.02 | 2.01 | 4.01 | 4.01 | 4.01 | 19.04 | 46.08 | 59.18 | 75.17 | 88.16 | 243 |
| Borrowings | 74.92 | 101 | 99.93 | 110 | 106 | 109 | 87.95 | 78.83 | 76.92 | 84.86 | 99.90 | 0.00 |
| Other Liabilities | 39.19 | 33.17 | 31.15 | 36.17 | 31.15 | 26.12 | 24.11 | 41.10 | 34.11 | 61.29 | 108 | 52.74 |
| Total Liabilities | 131 | 151 | 141 | 157 | 148 | 147 | 138 | 173 | 177 | 229 | 304 | 305 |
| Fixed Assets | 31.09 | 79.17 | 74.15 | 71.19 | 69.15 | 71.20 | 66.18 | 71.15 | 79.24 | 75.23 | 129 | 157 |
| CWIP | 48.10 | 2.01 | 3.01 | 3.01 | 3.01 | 0.00 | 1.01 | 7.01 | 1.01 | 45.12 | 35.09 | 6.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 52.93 | 69.98 | 63.92 | 82.97 | 75.88 | 75.92 | 70.93 | 94.84 | 96.95 | 109 | 141 | 142 |
| Inventories | 20.01 | 28.03 | 21.99 | 30.99 | 28.04 | 28.99 | 26.01 | 29.01 | 35.99 | 42.99 | 57.01 | 52.05 |
| Trade receivables | 12.05 | 26.09 | 27.12 | 30.12 | 27.12 | 28.10 | 29.13 | 41.13 | 40.12 | 48.16 | 64.21 | 71.31 |
| Cash & equivalents | 0.00 | 1.99 | 0.99 | 2.99 | 1.99 | 0.99 | 3.99 | 5.99 | 1.99 | 0.99 | 3.99 | 13.96 |
| Total Assets | 131 | 151 | 141 | 157 | 148 | 147 | 138 | 173 | 177 | 229 | 304 | 305 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 12.99 | 0.99 | 11.99 | 1.99 | 14.98 | 18.98 | 34.95 | 32.95 | 13.99 | 41.98 | 47.99 | 9.99 |
| Cash from investing activity | −31.07 | −17.05 | −3.01 | −4.01 | −2.01 | −7.02 | −4.01 | −17.04 | −9.02 | −40.09 | −50.14 | −20.05 |
| Cash from financing activity | 14.99 | 17.99 | −7.99 | 2.99 | −29.99 | −23.99 | −6.99 | −8.99 | −11.01 | −10.99 | 1.99 | 33.97 |
| Net cash flow | −3.01 | 2.01 | 1.01 | 1.01 | −18.03 | −11.01 | 23.01 | 7.01 | −5.01 | −9.01 | −1.01 | 23.01 |
| Capex | 30.72 | 22.65 | 3.38 | 3.94 | 2.11 | 6.77 | 3.85 | 16.39 | 8.23 | 41.53 | 49.96 | 20.12 |
| Free cash flow | −18.06 | −22.08 | 8.03 | −2.01 | 12.04 | 13.04 | 32.12 | 17.05 | 6.02 | 1.01 | −2.01 | −11.03 |
| CFO / OP % | 645.1% | 8.0% | 128.0% | 14.1% | 90.0% | 114.0% | 125.1% | 131.0% | 57.0% | 115.0% | 156.0% | 33.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 37 | 63 | 61 | 60 | 52 | 58 | 54 | 63 | 61 | 63 | 65 | 60 |
| Inventory days | 86 | 100 | 76 | 91 | 81 | 92 | 79 | 66 | 83 | 84 | 79 | 59 |
| Days payable | 69 | 90 | 70 | 69 | 59 | 71 | 62 | 73 | 53 | 78 | 82 | 41 |
| Cash conversion cycle | 53 | 73 | 66 | 81 | 73 | 78 | 70 | 54 | 90 | 68 | 61 | 77 |
| Working capital days | −68 | −20 | −57 | −52 | −91 | −27 | 3 | 8 | 42 | −20 | −45 | 71 |
| ROCE % | −1.0% | 7.0% | 3.0% | 10.0% | 11.0% | 10.0% | 19.9% | 20.9% | 19.0% | 21.9% | 14.9% | 19.9% |
For the Mar 2026 quarter, Sunshield Chemicals reported sales of ₹110 Cr, up 0.1% year on year and net profit of ₹11.03 Cr, up 83.2% year on year. The operating margin was 15.0%.
Sunshield Chemicals' sales for the year to Mar 2026 were ₹442 Cr; over the last twelve months they were ₹442 Cr.
Net profit for the year to Mar 2026 was ₹30.08 Cr, and ₹30.10 Cr over the last twelve months. Earnings per share over the same trailing period were ₹33.65.
Sunshield Chemicals reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹13.96 Cr.
Cash from operations was ₹9.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹11.03 Cr.